A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

Completed · NCT05467176

Conditions: Prostate Cancer

Research payments reported, 2025: $1.5M
U.S. investigators named: 67
Sites paid: 65
Planned or actual enrollment: 999

About the trial

Sponsor: Sumitomo Pharma America, Inc.
Tested: Relugolix (drug)
Dates: Started 2022-10-04; completion 2026-06-30
Results posted: Not yet

This is a multi-center, prospective, observational study of patients being treated with ORGOVYX. The goal of this study is to generate real-world evidence about the safety and effectiveness of ORGOVYX in patients with prostate cancer in routine clinical care and the clinical course during treatment with and following cessation of ORGOVYX.

From ClinicalTrials.gov, last updated 2026-07-13. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Sumitomo Pharma America, Inc. reported $1.5M in research payments for this study in 2025 (494 payments).

Products named: Orgovyx

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Urologic Surgeons of Washington Chartered $86,803
Urology Centers of Alabama $85,515
The Urology Place $73,170
Premier Clinical Research DBA Stat Research $71,808
Urology Austin PLLC $57,701
Summit Medical Group PA $56,507
Gu Inc $51,370
Northwestern University $45,118
The Conrad Pearson Clinic $44,594
Urology of Virginia PLLC $43,063
Urology Associates PC $41,171
Urosurgery Associates LLC DBA Urologic Specialists $40,940
University Hospitals Cleveland Medical Center $38,163
Portercare Adventist Health System $37,521
Lowcountry Urology Clinics PA $37,307
Neo Urology Associates Inc $37,250
Wichita Urology Group PA $36,923
Minnesota Urology PA $30,045
Associated Medical Professionals of Ny PLLC $28,530
Uropartners LLC $27,493
Nextstage Clinical Research LLC $26,184
Wisconsin Institute of Urology $26,145
Stamford Hospital, CT $26,097
Potomac Urology Center PC $25,621
Atlanticare Regional Medical Center - City Campus, NJ $23,980
Arizona Urology Specialists PLLC $21,279
Associated Urologists of North Carolina $19,961
Genesis Research LLC $19,954
The Regents of the University of Ca San Diego $18,779
Specialty Clinical Research of St Louis LLC $18,446
Urology Associates of Mobile PA $16,976
Arkansas Urology Research Center LLC $16,932
Emory University Hospital, GA $14,953
Urology San Antonio PA DBA USA Clinical Trials $14,272
Georgetown University $14,000
Medatlantic Inc $13,809
Southern Urology LLC $13,589
Chesapeake Urology Associates $13,201
Kumc Research Institute Inc $11,345
Empirican Prn DBA Circuit Clinical $11,038
Spokane Urology Ps $10,955
Memorial Regional Hospital, FL $10,901
Manatee Medical Research Institute LLC $10,118
Carolina Urologic Research Center LLC $9,398
Comprehensive Urologic Care Sc $8,916
Prisms Group LLC $8,544
University of Toledo $8,500
Baptist Health Lexington, KY $8,490
Icahn School of Medicine at Mount Sinai $8,195
Pharmaseek LLC $8,000
Lancaster Urology PC DBA Keystone Urology Special $7,742
Michigan Institute of Urology PC $6,253
Denver Research Institute $6,004
St Josephs Hospital and Medical Center, AZ $4,930
Wynn Hospital, NY $4,557
Tower Urology $4,250
The Valley Hospital Inc DBA the Valley Hospital $4,019
Advanced Urology Institute $4,000
Golden State Urology $3,489
University Health System, Inc, TN $3,000
Optum Medical Care PC $2,855
Kerlo Research Inc $2,500
Tri-Valley Urology Medical Group Philip Brodak Eta $2,474
Urology Associates of Central Ca Medical Group Inc $2,266
Urology of Indiana LLC $1,510

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.

At a glance

About the trial

Industry funding

U.S. investigators named on this study

Sites paid to run it